The partnership will provide the MedTech industry with specialized penetration testing services leading to more secure and therefore safer and more effective devices, and in turn, accelerate regulatory approval
SAN DIEGO, June 12, 2023 /PRNewswire/ — MedCrypt, Inc., the proactive cybersecurity solutions provider for medical device manufacturers, including seven of the top 10, today announced its partnership with Stratigos Security, a company that specializes in penetration testing and independent security assessments. Together, they offer a suite of third-party assessment and advisory services, with specialized penetration tests for medical device makers to assure the safety and effectiveness of their devices.
In March 2023, the Food and Drug Administration (FDA) announced that beginning October 1, 2023, it will “refuse to accept” medical devices that fail to meet cybersecurity requirements, further highlighting the need for developers to design and maintain products that align with the FDA’s pre- and post-market guidance.
Conventional penetration tests are a poor fit for assessing medical device safety and effectiveness risks. The MedCrypt-Stratigos partnership provides…
